|
Management
- Frank Lloyd, Jr, MD, is the Co-founder and President of Cascade Metrix. He is leading the clinical operations of Cascade, in addition to helping raise private investments. He has led clinical research and development through his association with industry and academia for more than 20 years. He also holds appointments as a Clinical Associate Professor in Surgery at the Indiana University School of Medicine, President of the Center of Surgical Sciences and Trauma, and Medical Director of Methodist Research Institute.
- Kislaya Kunjan is the Co-founder and Chief Technology Officer of Cascade Metrix. He is the lead inventor of the product technology and is managing the company's product and business development aspects in collaboration with its partners and strategic investors alike. He holds an M.S. in Mechanical Engineering from Purdue and an MBA from Cornell University. While at Purdue, he designed and developed a novel infrared glucose sensing system under the mentorship of Prof. Jay Gore. His prior professional experience spans sales engineering with Saint-Gobain, medical device development with Vista Biosciences and most recently a product management role with J&J/LifeScan.
- David T. Giddings is a Co-Founder and serves as Chief Business Officer (CBO) of Cascade Metrix. His business career has been focused on healthcare, information technology, and life sciences businesses with both established and emerging publicly & privately held companies. He was with Eastman Kodak in General Management positions in Kodak's Commercial Imaging and Information Systems and Healthcare Groups in addition to serving at the Corporate Officer Level. Mr. Giddings joined Boehringer Mannheim Corporation in 1991 as VP and General Manager of their Diagnostics Division and subsequently became President and COO of the company. He was appointed Chairman, President, and CEO of Diametrics Medical in 1995, a NASDAQ traded company, where he served for 6 years. Mr. Giddings served as Digilab Inc’s President & CEO until July, 2009, and remains an active shareholder in the company.
Advisory Board
- Rattan Juneja, MD, is the Medical Director, IU Diabetes Center and Chief of Endocrinology, Wishard Memorial Hospital, IN. Dr. Juneja and co-workers have developed an innovative intravenous insulin infusion protocol ("Glucostabilizer") to treat inpatient hyperglycemia. He is also a founding member of Diabetes Innovations, LLC.
- Pete Kissinger, Ph.D., is the founder of Bioanalytical Systems, Inc., (NASDAQ BASI) - a life science contract research firm, which he led from 1974-2007, and is Professor of Bioanalytical Chemistry at Purdue University. Dr. Kissinger has published more than 230 scientific papers and is a Fellow of the American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. In 2005, he became the Chairman of Prosolia, which markets mass spectrometry innovations for life science, industrial and homeland security applications. In 2007, he and Candice Kissinger founded Phlebotics, Inc., a medical device company focused on diagnostic information for intensive care medicine.
|
Home